Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:07 PM ET 8-K
Financial Results Rocket Lab Corp RKLB

Rocket Lab Financial Results

Rocket Lab reported record Q3 2026 revenue of $268 million, representing a 73% year-over-year increase, and achieved positive GAAP operating cash flow of $7.2 million. The company's total backlog grew 52% sequentially to $3.57 billion, driven by approximately $1 billion in new launch contracts and $470 million in Space Systems awards signed during the quarter.

Term
Q3 2026

“Q3 2026 was a defining quarter for Rocket Lab. We delivered a record $268 million in revenue ($34 million higher than Q2 2026) alongside a record backlog which has grown to $3.57 billion. Nearly $1 billion of that backlog comes from new launch contracts, signed in Q3 2026 alone, as well as $470 million signed for Space Systems. Our end-to-end space strategy is delivering exactly as designed: the world's most critical and ambitious missions increasingly rely on Rocket Lab for launch, spacecraft, and components, sometimes all on a single mission, and every part of our business is growing as a result.”

Sir Peter Beck, Rocket Lab founder and CEO
4:07 PM ET 10-Q
Financial Results Financial Institutions Inc FISI

Financial Institutions Q3 2026 Results: Net Income $20M, Down 2.4% YoY

Financial Institutions, Inc. reported net income of $19.99 million for the quarter ended September 30, 2026, compared to $20.48 million in the prior year period. While net interest income increased to $54.29 million, the company experienced a significant increase in accumulated other comprehensive loss due to unrealized losses on securities available for sale.

Key figure
Net income $20M · -2.4% YoY
4:07 PM ET 8-K
Other 8-K Filing Wheeler Real Estate Investment Trust, Inc. WHLR

Wheeler Real Estate Investment Trust Other 8-K Filing

Wheeler Real Estate Investment Trust entered into agreements to issue a total of 1,167,880 shares of common stock to unaffiliated holders in exchange for 40,589 shares of Series B and 4,550 shares of Series D Preferred Stock. The transactions were conducted as tax-free exchanges under Section 3(a)(9) of the Securities Act, resulting in the retirement and cancellation of the preferred shares with no cash proceeds received by the company.

4:07 PM ET Form 4
Insider Selling e.l.f. Beauty, Inc. ELF

e.l.f. Beauty SVP, Operations Joshua Allen Franks Sells $1.08M of Stock

Joshua Allen Franks, SVP, Operations, sold 8,965 shares of e.l.f. Beauty, Inc. at $120.00 to $122.00 a share (average $120.47) in 2 transactions, worth $1.08M in total on Nov 5, 2026. Shares held after the trade: 110,040 (-1.9%).

Value
$1.08M
Shares
8,965
Average price
$120.47
Role
SVP, Operations
Holding change
-1.9%
Trade date
Nov 5, 2026
4:07 PM ET 8-K
Financial Results Lifevantage Corp LFVN

Lifevantage Financial Results

LifeVantage Corp reported financial results for the first quarter of fiscal 2027, with revenue declining 22% to $37.1 million due to lower active accounts and GLP-1 system sales. The company reported a net loss of $0.02 per diluted share and is implementing a new strategy to transform into a brand-driven, consumer-focused company with a more efficient operating model.

Term
Q1 2027

“Despite a challenging quarter, LifeVantage has significant untapped potential, and we now have a clear strategy designed to capture it. Our focus is on transforming LifeVantage into a more brand-driven, consumer-focused company, supported by a modern digital platform and an expanding community of consumers and brand advocates.”

Terrence Moorehead, President and Chief Executive Officer
4:07 PM ET 10-Q
Financial Results HighPeak Energy, Inc. HPK

HighPeak Energy Q3 2026 Results: Net Loss of $55.7M, Loss Widens

HighPeak Energy, Inc. is an oil and gas company focused on the development of unconventional resources in the Permian Basin. As of November 5, 2026, the company had 126,539,533 shares of common stock outstanding and is classified as an accelerated filer. The filing includes updates to its credit facilities, including the Fourth Facility Amendment dated June 30, 2026.

Key figure
Net loss $55.7M
4:07 PM ET 8-K
Financial Results Kaltura Inc KLTR

Kaltura Financial Results

Kaltura reported record quarterly revenue of $47.3 million for Q3 2026, exceeding its guidance and achieving its highest third-quarter Adjusted EBITDA to date at $6.0 million. The company saw significant commercial traction in its AI offerings, signing 15 transactions representing $3.8 million in total contract value, and more than doubled its new subscription bookings sequentially.

Term
Q3 2026

“We delivered another strong quarter, exceeding the high end of our guidance for total revenue, subscription revenue and adjusted EBITDA, while achieving record quarterly total and subscription revenue, our highest third-quarter adjusted EBITDA to date, and strong positive cash flow from operations.”

Ron Yekutiel, Co-Founder, Chairman, President and Chief Executive Officer

“Third quarter new subscription bookings more than doubled sequentially, making it our strongest bookings quarter since 2024, highlighted also by three seven-figure new transactions.”

Ron Yekutiel, Co-Founder, Chairman, President and Chief Executive Officer
4:07 PM ET 8-K
Financial Results Natural Gas Services Group Inc NGS

Natural Gas Services Group Financial Results

Natural Gas Services Group reported Q3 2026 rental revenue of $58.9 million, a 41.9% year-over-year increase, and net income of $5.6 million. The company raised its full-year 2026 Adjusted EBITDA guidance to $105-$108 million and increased its quarterly dividend to $0.16 per share.

“NGS delivered another record quarter, marking the first full quarter of financial contribution from Flatrock. During the third quarter, rental revenue increased 42% year over year, Adjusted EBITDA increased 42% year over year, and horsepower utilization remained strong at 88%.”

Justin Jacobs, Chief Executive Officer

“Our strong operating performance supports the increase in our full-year 2026 Adjusted EBITDA guidance to $105 million to $108 million, raising the midpoint of our outlook. We are also increasing our quarterly dividend to $0.16 per share, reflecting growing earnings and confidence in the cash-generating capacity of our business.”

Justin Jacobs, Chief Executive Officer
4:07 PM ET 10-Q
Financial Results Septerna, Inc. SEPN

Septerna Q3 2026 Results: Net Loss of $26.6M

Septerna, Inc. is a clinical-stage biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery using its Native Complex Platform. As of November 4, 2026, the company had 47,549,223 shares of common stock outstanding and is classified as an emerging growth company and non-accelerated filer.

Key figure
Net loss $26.6M
4:07 PM ET 8-K
Financial Results Hyperfine, Inc. HYPR

Hyperfine Financial Results

Hyperfine reported record third-quarter 2026 revenue of $6.0 million, a 73% increase year-over-year, driven by the sale of 14 Swoop portable MRI systems. The company achieved its narrowest quarterly operating loss of $7.3 million and record gross margins of 57%. Management highlighted that quarterly revenue exceeded net cash burn for the first time, demonstrating significant operating leverage.

Term
Q3 2026

“Q3 2026 marked the beginning of a new trajectory for Hyperfine. We delivered record revenue, gross profit, and gross margin, and for the first time quarterly revenue exceeded net cash burn, demonstrating the operating leverage of our business.”

Maria Sainz, President and Chief Executive Officer of Hyperfine, Inc.

“Beyond our current business, I am excited about the opportunities for our Swoop® system in the evolving brain health and longevity fields. This is the new Hyperfine.”

Maria Sainz, President and Chief Executive Officer of Hyperfine, Inc.
4:07 PM ET 8-K
M&A Deal Park Dental Partners, Inc. PARK

Park Dental Partners M&A Deal with Village Family Dental

Park Dental Partners completed its acquisition of the dental services organization supporting Village Family Dental, expanding its footprint into North Carolina. The transaction adds support for 12 practice locations and 47 doctors to the company's network. In connection with the deal, the company amended its credit agreement to increase its revolving credit commitment from $15 million to $25 million.

Counterparty
Village Family Dental
4:07 PM ET 10-Q
Financial Results Natural Gas Services Group Inc NGS

Natural Gas Services Group Q3 2026 Results: Net Income $5.61M, Down 3.0% YoY

Natural Gas Services Group reported total revenue of $161.1 million for the nine months ended September 30, 2026, a significant increase from $126.2 million in the prior year, primarily driven by rental revenue growth. Net income for the period remained relatively stable at $16.2 million compared to $15.8 million in 2025, as higher operating costs and interest expenses offset the revenue gains.

Key figure
Net income $5.61M · -3.0% YoY
4:06 PM ET 10-Q
Financial Results Forward Air Corp FWRD ▶ Call

Forward Air Q3 2026 Results: Turns Profitable, Net Income $11.4M

Forward Air Corporation reported a return to profitability in the third quarter of 2026 with net income of $9.1 million, despite a significant year-to-date net loss of $277.0 million primarily driven by a $244.0 million goodwill impairment. Operating revenues for the nine months ended September 30, 2026, increased to $1.93 billion compared to $1.86 billion in the prior year period.

Key figure
Net income $11.4M
4:06 PM ET Form 4
Insider Selling Brunswick Corp BC

Brunswick E.V.P. & President Boat Group Brenna Preisser Sells $335K of Stock

Brenna Preisser, E.V.P. & President Boat Group, sold 4,300 shares of Brunswick Corp at $77.81 a share, worth $335K in total on Nov 6, 2026. Shares held after the trade: 90,427 (-4.5%).

Value
$335K
Shares
4,300
Price
$77.81
Role
E.V.P. & President Boat Group
Holding change
-4.5%
Trade date
Nov 6, 2026
4:06 PM ET Form 4
Insider Selling California Water Service Group CWT

California Water Service Group Director Thomas M. Krummel Sells $188K of Stock

Thomas M. Krummel, Director, sold 3,700 shares of California Water Service Group at $50.81 a share, worth $188K in total on Nov 6, 2026. Shares held after the trade: 16,404 (-18.4%).

Value
$188K
Shares
3,700
Price
$50.81
Role
Director
Holding change
-18.4%
Trade date
Nov 6, 2026
4:06 PM ET 8-K
Financial Results Thryv Holdings, Inc. THRY

Thryv Holdings Financial Results

Thryv Holdings reported Q3 2026 financial results, highlighting its transition to a pure-play SaaS business following the upcoming sale of its print directories unit. SaaS revenue reached $112.0 million with a monthly ARPU of $373, though the company recorded a consolidated net loss of $116.0 million primarily due to a $94.8 million non-cash goodwill impairment charge.

Term
Q3 2026

“We delivered a solid third quarter, driven by strong momentum and customer adoption of our new AI-powered Thryv Growth Platform™. As a result of the upcoming sale of our print directories business and our ongoing strategic restructuring, Thryv is now positioned to operate as a pure-play SaaS company.”

Joe Walsh, CEO of Thryv
4:06 PM ET 10-Q
Financial Results Zapata Quantum, Inc. ZPTA

Zapata Quantum Q3 2026 Results: Net Loss of $2.9M

Zapata Quantum, Inc. reported a net loss of $6.04 million for the nine months ended September 30, 2026, compared to a net income of $5.20 million in the prior year period. The company's cash position significantly improved to $11.24 million from $1.66 million at the end of 2025, primarily driven by the sale of Series D Preferred stock.

Key figure
Net loss $2.9M
4:06 PM ET 8-K
Financial Results ArriVent BioPharma, Inc. AVBP

ArriVent BioPharma Financial Results

ArriVent BioPharma reported Q3 2026 financial results, highlighting a cash position of $393.2 million and progress in its Phase 3 ALPACCA study. The company also announced the retirement of Stuart Lutzker, M.D., Ph.D., as President of R&D, with Chief Medical Officer Priti Patel, M.D., assuming leadership of the R&D function.

Term
Q3 2026

“Enrollment remains on track for our global Phase 3 ALPACCA trial in first line EGFR PACC mutant NSCLC patients. While FURVENT did not meet its primary endpoint, firmonertinib demonstrated clear antitumor activity, with an efficacy and safety profile consistent with prior studies.”

Bing Yao, Ph.D., CEO of ArriVent
4:06 PM ET Form 4
Insider Buying SOPHiA Genetics SA SOPH

SOPHiA Genetics CFO George Cardoza Buys $141K of Stock

George Cardoza, CFO, bought 20,000 shares of SOPHiA Genetics SA at $7.06 a share, worth $141K in total on Nov 6, 2026. Shares held after the trade: 326,726 (+6.5%).

Value
$141K
Shares
20,000
Price
$7.06
Role
CFO
Holding change
+6.5%
Trade date
Nov 6, 2026
4:06 PM ET 8-K
Financial Results MBX Biosciences, Inc. MBX

MBX Biosciences Financial Results

MBX Biosciences reported third quarter 2026 financial results, highlighting the initiation of its pivotal Phase 3 oPTimize trial for canvuparatide in hypoparathyroidism. The company ended the quarter with $481.6 million in cash and investments, which is expected to fund operations into 2029.

Term
Q3 2026

“The third quarter marked an important milestone for MBX with the initiation of our pivotal Phase 3 oPTimize trial of once-weekly canvuparatide, a potential best-in-class PTH replacement therapy.”

Steve Hoerter, Chairman and Chief Executive Officer

“With a strong balance sheet and cash runway into 2029, we believe we are well positioned to advance canvuparatide through pivotal development while continuing to invest in our growing obesity portfolio.”

Steve Hoerter, Chairman and Chief Executive Officer
4:06 PM ET 10-Q
Financial Results Pra Group Inc PRAA

Pra Group Q3 2026 Results: Turns Profitable, Net Income $14.9M

For the nine months ended September 30, 2026, PRA Group reported total revenues of $973.0 million and net income attributable to the company of $101.0 million, a significant recovery from the $361.7 million net loss in the prior year period which was impacted by a $412.6 million goodwill impairment. Total assets stood at $5.23 billion as of September 30, 2026, with finance receivables remaining the largest asset class at $4.68 billion.

Key figure
Net income $14.9M
4:06 PM ET Form 4
Insider Buying SOPHiA Genetics SA SOPH

SOPHiA Genetics CEO Ross Muken Buys $137K of Stock

Ross Muken, CEO, bought 20,000 shares of SOPHiA Genetics SA at $6.86 a share, worth $137K in total on Nov 6, 2026. Shares held after the trade: 680,391 (+3.0%).

Value
$137K
Shares
20,000
Price
$6.86
Role
CEO
Holding change
+3.0%
Trade date
Nov 6, 2026
4:06 PM ET 8-K
Financial Results Sanmina Corp SANM

Sanmina Financial Results

Sanmina reported record fiscal 2026 results with revenue growing 79% to $14.53 billion, driven by double-digit growth in its core business and the integration of ZT Systems. The company also amended its credit agreement to add $70 million in incremental term loans and extend the maturity of its $1.5 billion revolving facility to 2031. For fiscal 2027, Sanmina issued optimistic guidance projecting revenue growth of approximately 27% at the midpoint.

Term
Q4 2026

“This was a transformative year for Sanmina as we delivered strong broad-based growth across all of our end markets, integrated the ZT Systems business, strengthening our position in the Cloud and AI Infrastructure end market, and grew our core Sanmina business by double digits year-over-year, maintaining a well-diversified portfolio.”

Jure Sola, Chairman and CEO of Sanmina Corporation

“Our fiscal 2026 results were exceptional. Revenue grew 79%, non-GAAP operating profit increased 130%, and non-GAAP diluted earnings per share more than doubled compared to a year ago.”

Jure Sola, Chairman and CEO of Sanmina Corporation
4:06 PM ET 8-K
Financial Results Siga Technologies Inc SIGA

Siga Technologies Financial Results

SIGA Technologies reported financial results for the third quarter ended September 30, 2026, showing total revenues of $1.3 million and a net loss of $2.9 million. The company highlighted a new $15 million procurement contract with the Canadian Department of National Defence for oral TPOXX and the retirement of its Chief Scientific Officer, Dr. Dennis Hruby.

“While we continue to work with the U.S. Government toward a new TPOXX procurement contract, our international business remains an important part of our strategy. We recently announced a $15 million contract with the Canadian Department of National Defence, a longstanding customer, and are actively pursuing opportunities with other international governments to further diversify our customer base over time.”

Diem Nguyen, Chief Executive Officer
4:06 PM ET 8-K
Financial Results Lantronix Inc LTRX

Lantronix Financial Results

Lantronix reported fiscal first quarter 2027 results with revenue increasing 8% year-over-year to $32.4 million, driven by a 37% surge in Embedded IoT Solutions. The company improved its GAAP net loss to $0.5 million and reaffirmed its outlook for double-digit revenue growth for the full fiscal year 2027.

Term
Q1 2027

“We entered fiscal 2027 from a position of strength, delivering 8% year-over-year revenue growth, non-GAAP gross margins above 45%, and a 50% increase in year-over-year non-GAAP net income.”

Saleel Awsare, president and CEO of Lantronix

“The strategic tuck-in acquisition of Nero Global Tracking has expanded our pro forma software and services mix above 10% of total revenue, supporting our strategy of building a more predictable, higher-margin revenue base.”

Saleel Awsare, president and CEO of Lantronix
4:06 PM ET 10-Q
Financial Results Radiant Logistics, Inc RLGT ▶ Call

Radiant Logistics Q1 2026 Results: Net Income $6.14M, Up 374.9% YoY

Radiant Logistics reported a significant increase in net income to $6.1 million for the quarter ended September 30, 2026, compared to $1.3 million in the prior year period, driven by higher revenues of $279.8 million. The company maintained a solid liquidity position with $27.8 million in cash and cash equivalents while managing an increase in operating expenses related to transportation costs and commissions.

Key figure
Net income $6.14M · +374.9% YoY
4:06 PM ET 8-K
Financial Results Annexon, Inc. ANNX

Annexon Financial Results

Annexon reported Q3 2026 financial results, highlighting a cash position of $213 million providing a runway into 2028. The company is preparing for a U.S. BLA submission for tanruprubart in GBS in Q4 2026 and expects a primary endpoint readout for its Phase 3 ARCHER II trial in geographic atrophy in Q4 2026.

Term
Q3 2026

“Annexon is well-positioned for a transformative next 12 months, with multiple value-creating milestones expected across our differentiated upstream C1q platform. By targeting C1q tanruprubart and vonaprument have each demonstrated first-in-kind benefits in clinical trials to date, with tanruprubart accelerating functional recovery in Guillain-Barré syndrome (GBS) and vonaprument protecting vision in geographic atrophy (GA).”

Douglas Love, President and Chief Executive Officer of Annexon
4:06 PM ET 8-K
M&A Deal Kustom Entertainment, Inc. KUST

Kustom Entertainment M&A Deal with Tfl, LLC

Kustom Entertainment, Inc. entered into an amendment to its definitive unit purchase agreement to acquire 100% of TFL, LLC (dba Tickets For Less). The amendment extends the outside termination date for the transaction from October 15, 2026, to December 18, 2026, to allow more time to satisfy customary closing conditions.

Counterparty
TFL, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.